Related Experiment Video
Updated: May 2, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target
Lu-Zhe Pan1, Dae-Gyun Ahn1, Tanveer Sharif1
1Department of Microbiology and Immunology; Dalhousie University; Halifax, Nova Scotia, Canada.
Abstract:
NAD(+) metabolism plays key roles not only in energy production but also in diverse cellular physiology. Aberrant NAD(+) metabolism is considered a hallmark of cancer. Recently, the tumor suppressor p53, a major player in cancer signaling pathways, has been implicated as an important regulator of cellular metabolism. This notion led us to examine whether p53 can regulate NAD(+) biosynthesis in the cell. Our search resulted in the identification of nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2), a NAD(+) synthetase, as a novel downstream target gene of p53. We show that NMNAT-2 expression is induced upon DNA damage in a p53-dependent manner. Two putative p53 binding sites were identified within the human NMNAT-2 gene, and both were found to be functional in a p53-dependent manner. Furthermore, knockdown of NMNAT-2 significantly reduces cellular NAD(+) levels and protects cells from p53-dependent cell death upon DNA damage, suggesting an important functional role of NMNAT-2 in p53-mediated signaling. Our demonstration that p53 modulates cellular NAD(+) synthesis is congruent with p53's emerging role as a key regulator of metabolism and related cell fate.
Insights
The tumor suppressor p53 regulates cellular metabolism by controlling NAD(+) biosynthesis. P53 targets NMNAT-2, impacting NAD(+) levels and cell death pathways, highlighting p53
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Metabolism
Background:
- NAD(+) metabolism is crucial for cellular energy and physiology.
- Dysregulated NAD(+) metabolism is a hallmark of cancer.
- The tumor suppressor p53 is a key regulator in cancer signaling and metabolism.
Purpose of the Study:
- To investigate if p53 regulates NAD(+) biosynthesis.
- To identify downstream targets of p53 involved in NAD(+) metabolism.
Main Methods:
- Identified nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) as a p53 target gene.
- Demonstrated p53-dependent induction of NMNAT-2 expression upon DNA damage.
- Validated functional p53 binding sites within the human NMNAT-2 gene.
- Assessed the impact of NMNAT-2 knockdown on cellular NAD(+) levels and p53-mediated cell death.
Main Results:
- NMNAT-2 is a novel downstream target gene of p53.
- NMNAT-2 expression is induced by DNA damage in a p53-dependent manner.
- NMNAT-2 knockdown reduces cellular NAD(+) levels and protects cells from p53-dependent death.
Conclusions:
- p53 modulates cellular NAD(+) synthesis through NMNAT-2.
- NMNAT-2 plays a functional role in p53-mediated signaling and cell fate.
- These findings support p53's role as a central regulator of metabolism and cell fate.
Related Concept Videos
Abnormal Proliferation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Biosynthesis of Nucleic Acids
Directionality of Nuclear Transport
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

